Phibro Animal Health Co. (NASDAQ:PAHC) Short Interest Update

Phibro Animal Health Co. (NASDAQ:PAHC) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 726,000 shares, a decline of 23.1% from the February 28th total of 943,800 shares. Approximately 3.6% of the company’s shares are short sold. Based on an average daily volume of 249,900 shares, the short-interest ratio is currently 2.9 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC raised its holdings in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after purchasing an additional 27,201 shares in the last quarter. Barclays PLC increased its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after acquiring an additional 29,271 shares in the last quarter. FMR LLC lifted its position in Phibro Animal Health by 22.7% during the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after acquiring an additional 7,270 shares during the period. BNP Paribas Financial Markets boosted its stake in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares in the last quarter. Finally, Smith Group Asset Management LLC bought a new stake in Phibro Animal Health during the fourth quarter worth about $541,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock opened at $21.17 on Monday. The business has a 50 day moving average of $22.78 and a 200 day moving average of $22.69. Phibro Animal Health has a 52 week low of $12.17 and a 52 week high of $26.55. The company has a market cap of $857.45 million, a PE ratio of 43.21, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities research analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on PAHC shares. Barclays increased their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, March 25th. Finally, Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.